REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
10.30
+0.34 (3.41%)
At close: Aug 4, 2026, 4:00 PM EDT
10.37
+0.07 (0.68%)
After-hours: Aug 4, 2026, 7:34 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $635.54 million as of August 4, 2026. Its market cap has increased by 54.71% in one year.
Market Cap
635.54M
Enterprise Value
733.44M
1-Year Change
54.71%
Ranking
Category
Stock Price
$10.30
ChartMarket Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $635.54M, a decrease of -15.18%. That is a compound annual growth rate of -1.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 514.90M | -29.37% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 641.06M |
| AgomAb Therapeutics NV | 633.82M |
| Crescent Biopharma | 619.33M |
| MiMedx Group | 601.99M |
| Immix Biopharma | 592.30M |
| CorMedix | 590.74M |
| MapLight Therapeutics | 590.40M |
| Contineum Therapeutics | 582.75M |